(Last updated : 2026-08-07 10:50:23)
  ISHIDA Hideki
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  
   Position   Professor
■ Books
1. Chapter contribution  Basiliximab 2021/08/25
2. Chapter contribution  For the prevention Antibody-Mediated rejection 2019/09
3. Chapter contribution  BK polyomavirus-associated nephropathy 2019/07
4. Chapter contribution  Viral infection after kidney transplantation 2019/06
5. Chapter contribution  Current situation of ABO-incompatible kidney transplantation in Japan., ABO-incompatible Kidney Transplantation 2016
■ Published papers
1. Original article  Significance of qualitative and quantitative evaluations of anti-HLA antibodies in kidney transplantation. 2011/02
2. Other  Comparison between IO–IO and IO–TKI combination therapies for renal cell carcinoma with inferior vena cava tumor thrombus. 2026/05 Link
3. Case report  Requiring caution in the interpretation of donor- derived cell- free DNA levels during cancer treatment in a kidney
transplant recipient.: A case report 2026/05
4. Original article  Clinical evaluation of medical and surgical complete responses in metastatic renal cell carcinoma treated with immune checkpoint inhibitor combination therapy. 2026/04
5. Original article  Feasibility and strategic endoscopic management of de novo kidney allograft stones: a retrospective study. 2026/04
Display all(223)
■ Academic conference presentation
1. Comparison between IO–IO and IO–TKI combination therapies for renal cell carcinoma with inferior vena cava tumor thrombus. (Poster notice,General) 2026/05/18
2. Surgical complications and risk factors in 2,095 cases of pure retroperitoneoscopic living donor nephrectomy: a 20-year experience. (Poster notice,General) 2026/04/24
3. Analyses of living kidney transplantation with crossmatch-positive cases (Speech,Panelist at Symposium/Workshop (Other)) 2026/04/23
4. Donor-derived nephritis on pre-transplant biopsy does not impair post-transplant renal function in recipients or donors. (Speech,General) 2026/04/23
5. HLA-F as a Novel Diagnostic Marker for Antibody-Mediated Rejection. (Poster notice,General) 2026/04/23
Display all(313)
■ Social activities
1. 2017/03 1st East Asia Transplant Expert Meeting Opening remarks